Found 7 matching trials
NAD Augmentation in Diabetes Kidney Disease
PHASE2A phase 2a trial randomized, double-blind, placebo-controlled, parallel gro...
Location
Brigham and Women's Hospital
Phase 2a MIB-626 vs. Placebo COVID-19
PHASE2The proposed phase 2a trial will determine whether MIB-626 treatment in adu...
Location
The Brigham and Women's Hospital
NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
PHASE1The aim of the study is to determine the safety and tolerability of differe...
Location
Massachusetts General Hospital
Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery
PHASE2The investigators will perform a phase 2a, randomized, double-blind, placeb...
Location
Brigham and Women's Hospital
NAD+ Precursor Supplementation in Friedreich's Ataxia
PHASE2The primary objective is to test the safety and tolerability of short-term ...
Location
The Children's Hospital of Philadelphia
Sirtuin-NAD Activator in Alzheimer's Disease
PHASE1The primary objectives are to:
1. To determine whether MIB-626, after its ...
Location
Brigham and Women's Hospital
Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program
PHASE2A single-center, randomized, placebo-controlled study in community dwelling...
Location
Brigham and Women's Hospital